|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lahue BJ, Baginska E, Li SS and Parisi M:
Health technology assessment on cervical cancer screening
2000–2014. Int J Technol Assess Health Care. 31:171–180. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Subramanian S, Trogdon J, Ekwueme DU,
Gardner JG, Whitmire JT and Rao C: Cost of cervical cancer
treatment: Implications for providing coverage to low-income women
under the Medicaid expansion for cancer care. Womens Health Issues.
20:400–405. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arbyn M, Castellsague X, de Sanjose S,
Bruni L, Saraiya M, Bray F and Ferlay J: Worldwide burden of
cervical cancer in 2008. Ann Oncol. 22:2675–2686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gómez-Gómez Y, Organista-Nava J and
Gariglio P: Deregulation of the miRNAs expression in cervical
cancer: Human papillomavirus implications. Biomed Res Int 2013.
4070522013.
|
|
6
|
Fish JE, Wythe JD, Xiao T, Bruneau BG,
Stainier DY, Srivastava D and Woo S: A Slit/miR-218/Robo regulatory
loop is required during heart tube formation in zebrafish.
Development. 138:1409–1419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alajez NM, Lenarduzzi M, Ito E, Hui AB,
Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, et al: miR-218
suppresses nasopharyngeal cancer progression through downregulation
of surviving and SLIT2-ROBO1 pathway. Cancer Res. 71:2381–2391.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Small EM, Sutherland LB, Rajagopalan KN,
Wang S and Olson EN: MicroRNA-218 regulates vascular patterning by
modulation of Slit-Robo signaling. Circ Res. 107:1336–1344. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao H, Anand AR and Ganju RK: Slit2-Robo4
pathway modulates lipopolysaccharide-induced endothelial
inflammation and its expression is dysregulated during endotoxemia.
J Immunol. 192:385–393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dickinson RE, Dallol A, Bieche I, Krex D,
Morton D, Maher ER and Latif F: Epigenetic inactivation of SLIT3
and SLIT1 genes in human cancers. Br J Cancer. 91:2071–2078. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Narayan G, Goparaju C, Arias-Pulido H,
Kaufmann AM, Schneider A, Dürst M, Mansukhani M, Pothuri B and
Murty VV: Promoter hypermethylation-mediated inactivation of
multiple Slit-Robo pathway genes in cervical cancer progression.
Mol Cancer. 5:162006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dallol A, Morton D, Maher ER and Latif F:
SLIT2 axon guidance molecule is frequently inactivated in
colorectal cancer and suppresses growth of colorectal carcinoma
cells. Cancer Res. 63:1054–1058. 2003.PubMed/NCBI
|
|
13
|
Xin SY, Feng XS, Zhou LQ, Sun JJ, Gao XL
and Yao GL: Reduced expression of circulating microRNA-218 in
gastric cancer and correlation with tumor invasion and prognosis.
World J Gastroenterol. 20:6906–6911. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ding H, Wu YL, Wang YX and Zhu FF:
Characterization of the MicroRNA expression profile of cervical
squamous cell carcinoma metastases. Asian Pac J Cancer Prev.
15:1675–1679. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng ZM and Wang X: Regulation of
cellular miRNA expression by human papillomaviruses. Biochim
Biophys Acta. 1809:668–677. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rao Q, Shen Q, Zhou H, Peng Y, Li J and
Lin Z: Aberrant microRNA expression in human cervical carcinomas.
Med Oncol. 29:1242–1248. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamamoto N, Kinoshita T, Nohata N, Itesako
T, Yoshino H, Enokida H, Nakagawa M, Shozu M and Seki N: Tumor
suppressive microRNA-218 inhibits cancer cell migration and
invasion by targeting focal adhesion pathways in cervical squamous
cell carcinoma. Int J Oncol. 42:1523–1532. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee H, Kim KR, Cho NH, Hong SR, Jeong H,
Kwon SY, Park KH, An HJ, Kim TH, Kim I, et al: MicroRNA expression
profiling and Notch1 and Notch2 expression in minimal deviation
adenocarcinoma of uterine cervix. World J Surg Oncol. 12:3342014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Banno K, Iida M, Yanokura M, Kisu I, Iwata
T, Tominaga E, Tanaka K and Aoki D: MicroRNA in cervical cancer:
OncomiRs and tumor suppressor miRs in diagnosis and treatment.
ScientificWorldJournal. 2014:1780752014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-218 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Uesugi A, Kozaki K, Tsuruta T, Furuta M,
Morita K, Imoto I, Omura K and Inazawa J: The tumor suppressive
microRNA miR-218 targets the mTOR component rictor and inhibits AKT
phosphorylation in oral cancer. Cancer Res. 71:5765–5778. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He H, Di Y, Liang M, Yang F, Yao L, Hao S,
Li J, Jiang Y, Jin C and Fu D: The microRNA-218 and ROBO-1
signaling axis correlates with the lymphatic metastasis of
pancreatic cancer. Oncol Rep. 30:651–658. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang M, Liu R, Sheng J, Liao J, Wang Y,
Pan E, Guo W, Pu Y and Yin L: Differential expression profiles of
microRNAs as potential biomarkers for the early diagnosis of
esophageal squamous cell carcinoma. Oncol Rep. 29:169–176. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tu K, Li C, Zheng X, Yang W, Yao Y and Liu
Q: Prognostic significance of miR-218 in human hepatocellular
carcinoma and its role in cell growth. Oncol Rep. 32:1571–1577.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bai XY, Lin JY, Zhang XC, Xie Z, Yan HH,
Chen ZH, Xu CR, An SJ, Sheng GM and Wu YL: High expression of
truncated GLI3 is associated with poor overall survival in patients
with non-small cell lung cancer. Cancer Biomark. 13:37–47. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-delta delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F:
Cancerincidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dappa E, Elger T, Hasenburg A, Düber C,
Battista MJ and Hötker AM: The value of advanced MRI techniques in
the assessment of cervical cancer: A review. Insights Imaging.
8:471–481. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang HY, Kim G, Cho H, Kim S, Lee D, Park
S, Park KH and Lee H: Diagnostic performance of HPV E6/E7, hTERT,
and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded
cervical tissue specimens from women with cervical cancer. Exp Mol
Pathol. 98:510–516. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arbyn M, Castellsagué X, de Sanjosé S,
Bruni L, Saraiya M, Bray F and Ferlay J: Worldwide burden of
cervical cancer in 2008. Ann Oncol. 22:2675–2686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo Q, Zhang S, Wei H, Pang X and Zhang H:
Roles of Foxp3 in the occurrence and development of cervical
cancer. Int J Clin Exp Pathol. 8:8717–8730. 2015.PubMed/NCBI
|
|
32
|
Burd EM: Human papillomavirus and cervical
cancer. Clin Microbiol Rev. 16:1–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nour NM: Cervical cancer: A preventable
death. Rev Obstet Gynecol. 2:240–244. 2009.PubMed/NCBI
|
|
34
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:1–866. 2006. View Article : Google Scholar
|
|
35
|
Kogo R, How C, Chaudary N, Bruce J, Shi W,
Hill RP, Zahedi P, Yip KW and Liu FF: The microRNA-218~survivin
axis regulates migration, invasion, and lymph node metastasis in
cervical cancer. Oncotarget. 6:1090–1100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu J, Wang Y, Dong R, Huang X, Ding S and
Qiu H: Circulating MicroRNA-218 was reduced in cervical cancer and
correlated with tumor invasion. J Cancer Res Clin Oncol.
138:671–674. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yuan W, Xiaoyun H, Haifeng Q, Jing L,
Weixu H, Ruofan D, Jinjin Y and Zongji S: MicroRNA-218 enhances the
radiosensitivity of human cervical cancer via promoting radiation
induced apoptosis. Int J Med Sci. 11:691–696. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hartono D, Lioe B, Zhang Y, Li B and Yu J:
Impacts of particulate matter (PM2.5) on the behavior of freshwater
snail Parafossarulus striatulus. Sci Rep. 7:6442017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tang BB, Liu SY, Zhang YU, Wei LQ, Mao XL,
Wang J, Li LI and Lu ZX: microRNA-218 expression and its
association with the clinicopathological characteristics of
patients with cervical cancer. Exp Ther Med. 10:269–274. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Steg A, Amm HM, Novak Z, Frost AR and
Johnson MR: Gli3 mediates cell survival and sensitivity to
cyclopamine in pancreaticcancer. Cancer Biol Ther. 10:893–902.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Iwasaki H, Nakano K, Shinkai K, Kunisawa
Y, Hirahashi M, Oda Y, Onishi H and Katano M: Hedgehog Gli3
activator signal augments tumorigenicity of colorectal cancer via
upregulation of adherence-related genes. Cancer Sci. 104:328–336.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kang HN, Oh SC, Kim JS and Yoo YA:
Abrogation of Gli3 expression suppresses the growth of colon
cancercells via activation of p53. Exp Cell Res. 318:539–549. 2012.
View Article : Google Scholar : PubMed/NCBI
|
